Literature DB >> 6135844

Antibodies to ATLV (HTLV) in Nigerian blood donors and patients with chronic lymphatic leukaemia or lymphoma.

A F Fleming, N Yamamoto, S R Bhusnurmath, R Maharajan, J Schneider, G Hunsmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6135844     DOI： 10.1016/s0140-6736(83)90306-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

Review 2.  Infectious diseases in Africa.

Authors:  E A Ayoola
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

3.  Antibodies to ATLV/HTLV-1 in Africa.

Authors:  G Hunsmann; H Bayer; J Schneider; H Schmitz; P Kern; M Dietrich; D W Büttner; A M Goudeau; G Kulkarni; A F Fleming
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

4.  Antibodies to adult T-cell leukemia virus (ATLV/HTLV-I) in AIDS patients and people at risk of AIDS in Germany.

Authors:  G Hunsmann; J Schneider; H Bayer; H Berthold; K Schimpf; H Kabisch; K Ritter; U Bienzle; H Schmitz; P Kern
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

5.  Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.

Authors:  L Ratner; S F Josephs; B Starcich; B Hahn; G M Shaw; R C Gallo; F Wong-Staal
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea.

Authors:  M P Sherman; N K Saksena; D K Dube; R Yanagihara; B J Poiesz
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Rat lymphoid cell lines with HTLV-I production. III. Transmission of HTLV-I into rats and analysis of cell surface antigens associated with HTLV-I.

Authors:  T Yoshiki; N Kondo; T Chubachi; M Tateno; T Togashi; T Itoh
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.

Authors:  Idris Durojaiye; Akinsegun Akinbami; Adedoyin Dosunmu; Sarah Ajibola; Adewumi Adediran; Ebele Uche; Olajumoke Oshinaike; Majeed Odesanya; Akinola Dada; Olaitan Okunoye
Journal:  Pan Afr Med J       Date:  2014-04-21

9.  Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria.

Authors:  Augustine Ejike Okoye; Obike Godswill Ibegbulam; Robinson Chukwudi Onoh; Ngozi Immaculata Ugwu; Chukwudi Simon Anigbo; Charles Emeka Nonyelu
Journal:  J Blood Med       Date:  2015-01-19

10.  Seroprevalence of human T-lymphotropic virus antibodies among patients with lymphoid malignancies at a tertiary center in Lagos, Nigeria.

Authors:  Akinsegun Akinbami; Idris Durojaiye; Adedoyin Dosunmu; Sarah John-Olabode; Adewumi Adediran; Olajumoke Oshinaike; Ebele Uche; Akinola Dada; Mojeed Odesanya; Olaitan Okunoye
Journal:  J Blood Med       Date:  2014-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.